China Resources Pharmaceutical Group Limited Share Price
Stocks
3320
HK0000311099
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Hong Kong S.E.
01:38:16 07/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 4.425 HKD | -0.23% |
|
-1.01% | -0.56% |
| 01/09 | China Resources Pharma Unit's Bond Program Registration Accepted in China | MT |
| 24/08 | China Resources Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 2.79TCr 355.34Cr 305.77Cr 287.69Cr 262.8Cr 491.62Cr 34TCr 492.96Cr 3.4TCr 1.32TCr 17TCr 1.33TCr 1.31TCr 55TCr | P/E 2026 * |
5.7x | P/E 2027 * | 5.35x |
|---|---|---|---|---|---|
| Enterprise Value | 7.71TCr 983.24Cr 846.08Cr 796.04Cr 727.18Cr 1.36TCr 93TCr 1.36TCr 9.41TCr 3.65TCr 48TCr 3.69TCr 3.61TCr 1,53400Cr | EV / Sales 2026 * |
0.23x | EV / Sales 2027 * | 0.21x |
| Free-Float |
29.17% | Yield 2026 * |
4.53% | Yield 2027 * | 4.89% |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 3320 | Delayed | |
Boerse Muenchen
| 640 | Real-time | |
|
Tradegate
| 640 | Real-time | |
|
Deutsche Boerse AG
| 640 | Delayed | |
|
Börse Stuttgart
| 640 | Delayed |
| 1 day | -0.23% | ||
| 1 week | -1.01% | ||
| Current month | -1.01% | ||
| 1 month | -8.57% | ||
| 3 months | -6.84% | ||
| 6 months | -2.75% | ||
| Current year | -0.56% |
| 1 week | 4.38 |  | 4.5 |
| 1 month | 4.38 | | 5.02 |
| Current year | 4.22 | | 6.53 |
| 1 year | 4.22 | | 6.53 |
| 3 years | 4.22 | | 7.11 |
| 5 years | 3.18 | | 8.13 |
| 10 years | 3.18 | | 13.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Cheng
PSD | President | 47 | 26/08/2025 |
Rong Hui Deng
DFI | Director of Finance/CFO | 54 | 13/06/2023 |
Wing Yi Wan
SEC | Corporate Secretary | - | 15/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ting Mei Fu
BRD | Director/Board Member | 59 | 01/06/2016 |
Ke Jian Zhang
BRD | Director/Board Member | 70 | 20/06/2016 |
Xiao Song Bai
CHM | Chairman | 55 | 29/08/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/04/20 | Other | Chief Executive Officer | 2,00,000 | 0.0032% | ||
| 31/03/20 | Other | Chief Executive Officer | 1,00,000 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.23% | -1.01% | -10.43% | -10.43% | 355.34Cr | |
| -0.88% | -2.15% | +58.05% | +105.26% | 1,02400Cr | |
| -1.15% | +2.68% | +54.25% | +74.19% | 66TCr | |
| -1.44% | +0.38% | +20.65% | +76.13% | 45TCr | |
| -0.53% | +0.48% | +31.25% | +38.13% | 35TCr | |
| -2.15% | +2.55% | +23.53% | +42.62% | 30TCr | |
| +1.20% | +1.69% | +1.63% | +12.39% | 25TCr | |
| -1.55% | +1.11% | +54.15% | +75.59% | 24TCr | |
| -0.07% | +2.22% | -13.85% | -55.80% | 21TCr | |
| -0.15% | +3.65% | +31.24% | +103.39% | 19TCr | |
| Average | -0.69% | +0.84% | +25.05% | +46.14% | 36.82TCr | |
| Weighted average by Cap. | -0.88% | +0.62% | +37.80% | +67.02% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33TCr 4.18TCr 3.6TCr 3.39TCr 3.09TCr 5.79TCr 3,95100Cr 5.81TCr 40TCr 16TCr 2,02700Cr 16TCr 15TCr 6,53000Cr | 34TCr 4.35TCr 3.74TCr 3.52TCr 3.21TCr 6.01TCr 4,10300Cr 6.03TCr 42TCr 16TCr 2,10500Cr 16TCr 16TCr 6,78200Cr |
| Net income | 479.7Cr 61Cr 53Cr 50Cr 45Cr 85Cr 5.78TCr 85Cr 585.27Cr 227.11Cr 2.96TCr 229.72Cr 224.71Cr 9.55TCr | 515.65Cr 66Cr 57Cr 53Cr 49Cr 91Cr 6.21TCr 91Cr 629.14Cr 244.13Cr 3.19TCr 246.94Cr 241.56Cr 10TCr |
| Net Debt | 4.92TCr 627.9Cr 540.31Cr 508.35Cr 464.38Cr 868.72Cr 59TCr 871.09Cr 6.01TCr 2.33TCr 30TCr 2.36TCr 2.31TCr 98TCr | 4.25TCr 542.37Cr 466.71Cr 439.11Cr 401.13Cr 750.38Cr 51TCr 752.43Cr 5.19TCr 2.01TCr 26TCr 2.04TCr 1.99TCr 85TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/26/07 | HK$4.425 | -0.23% | 1,03,64,000 |
| 04/26/04 | HK$4.435 | +0.57% | 1,00,75,658 |
| 03/26/03 | HK$4.410 | 0.00% | 89,85,000 |
| 02/26/02 | HK$4.410 | -0.79% | 1,20,10,600 |
| 01/26/01 | HK$4.445 | -0.56% | 1,06,13,082 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 3320 Stock
Select your edition
All financial news and data tailored to specific country editions
